These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new fetal therapy for chylothorax: pleurodesis with OK-432. Okawa T; Takano Y; Fujimori K; Yanagida K; Sato A Ultrasound Obstet Gynecol; 2001 Oct; 18(4):376-7. PubMed ID: 11778999 [TBL] [Abstract][Full Text] [Related]
4. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678 [TBL] [Abstract][Full Text] [Related]
5. A case of successful fetal therapy for congenital chylothorax by intrapleural injection of OK-432. Tanemura M; Nishikawa N; Kojima K; Suzuki Y; Suzumori K Ultrasound Obstet Gynecol; 2001 Oct; 18(4):371-5. PubMed ID: 11778998 [TBL] [Abstract][Full Text] [Related]
6. OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia. Ogawa K; Takahashi Y; Murase K; Hanada S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Kurosaki A; Kishi K Respir Investig; 2018 Sep; 56(5):410-417. PubMed ID: 29903606 [TBL] [Abstract][Full Text] [Related]
7. [High efficacy of pleurodesis using OK-432 for controlling intractable pneumothorax associated with pulmonary lymphangioleiomyomatosis]. Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Narui K; Yoshimura K; Nakata K Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):704-7. PubMed ID: 14584389 [TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. Sitter T; Schmidt M; Schneider S; Schiffl H J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602 [TBL] [Abstract][Full Text] [Related]
9. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc. Shinno Y; Kage H; Chino H; Inaba A; Arakawa S; Noguchi S; Amano Y; Yamauchi Y; Tanaka G; Nagase T Respirology; 2018 Jan; 23(1):55-59. PubMed ID: 28980363 [TBL] [Abstract][Full Text] [Related]
10. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis. Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients]. Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916 [TBL] [Abstract][Full Text] [Related]
12. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection]. Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289 [TBL] [Abstract][Full Text] [Related]
13. [Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)]. Tanaka A; Sato T Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):531-7. PubMed ID: 10481458 [TBL] [Abstract][Full Text] [Related]
14. Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion. Ko YC; Wu WP; Hsu CS; Dai MP; Ou CC; Kao CH J Korean Med Sci; 2009 Jun; 24(3):398-402. PubMed ID: 19543500 [TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432. Oishi K; Kitano T; Mizumaki K; Maeda S; Saito D; Yoshida S; Matsumoto I; Takehara K; Hamaguchi Y Eur J Dermatol; 2018 Aug; 28(4):520-521. PubMed ID: 30105988 [No Abstract] [Full Text] [Related]
16. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862 [TBL] [Abstract][Full Text] [Related]
17. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395 [TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623 [TBL] [Abstract][Full Text] [Related]
19. Treating carcinomatous pleural effusion by intrapleural injection of OK-432 in patients with non-small-cell lung cancer. Chao TY; Hwang WS Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):229-34. PubMed ID: 8258114 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of PCT, CRP, ESR, WBC count as predictors in postoperative early infectious complications with fever after posterior lumbar internal fixation]. Wang L; Yang B; Yin B; Zhang Z; Zhang L; Tang L; Lou AJ Zhongguo Gu Shang; 2015 Jan; 28(1):66-70. PubMed ID: 25823137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]